Steroid hypothermia

Area of Science:

• Critical Care Medicine
• Pharmacology
• Infectious Diseases

Background:

• Septic shock is a life-threatening condition characterized by circulatory dysfunction and organ hypoperfusion.
• Fever is a common clinical sign in septic shock, often indicating a systemic inflammatory response.
• The role of corticosteroids in managing septic shock remains an area of clinical interest.

Purpose of the Study:

• To evaluate the efficacy of Solu-Medrol (methylprednisolone sodium succinate) in managing fever in patients with septic shock.
• To assess the impact of Solu-Medrol treatment on the general physical condition of septic shock patients.

Main Methods:

• Retrospective analysis of 17 episodes of septic shock.
• Intravenous administration of a 2-gram bolus of Solu-Medrol.
• Monitoring of patient temperature and general physical condition post-treatment.

Main Results:

• A rapid decrease in temperature was observed within four hours in most patients treated with Solu-Medrol.
• Accompanying the fever reduction, patients showed improvement in their general physical condition.
• The hypothermic effect typically lasted approximately 30 hours, with temperature returning to or falling below pre-treatment levels.

Conclusions:

• Intravenous Solu-Medrol bolus administration is effective in rapidly reducing fever in septic shock patients.
• The treatment appears to improve the overall clinical status of patients experiencing septic shock.
• In non-survivors with overwhelming sepsis, the temperature response was less pronounced and shorter in duration.